Filamentous particle formation by human parainfluenza virus type 2.
Some paramyxoviruses form long filamentous virus particles: however, the determinants of filament formation and the role of such particles in virus transmission and pathogenicity are not clearly defined. By using conventional immunofluorescence microscopy, we found that human parainfluenza virus type 2 (HPIV2) forms filamentous particles ranging from 5 to 15 microm in length in virus-infected, polarized epithelial cells. The formation of filamentous particles was found to be virus type-specific and was not observed when the same cell types were infected with parainfluenza virus type 3 or Sendai virus, suggesting that different paramyxovirus genera exhibit distinct morphological properties. HPIV2 filamentous particle formation was found to be inhibited by cytochalasin D (CD) or jasplakinolide treatment in a dose-dependent manner. In the presence of 4 microg/ml CD or 1 microM jasplakinolide, the formation of filamentous particles was completely abolished, although similar haemagglutination and p.f.u. titres of virus were found to be released into the culture medium at 24 h post-infection. These observations indicate that host cell components, including the actin microfilament network, are important determinants of the morphology of parainfluenza viruses. The predominance of filamentous particles in polarized epithelial cells may reflect specific pathogenic roles of these particles in infection of human epithelial tissues.
Yao
Q
Q
Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Compans
R W
RW
D000199:Actins / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D002460:Cell Line; D002522:Chlorocebus aethiops; D015638:Cytochalasin D / Q000494:pharmacology; D047630:Depsipeptides; D004285:Dogs; D005455:Fluorescent Antibody Technique; D006386:Hemagglutination Tests; D006801:Humans; D010223:Parainfluenza Virus 2, Human / Q000378:metabolism*; D010456:Peptides, Cyclic / Q000494:pharmacology; D014709:Vero Cells; D010948:Viral Plaque Assay; D014771:Virion / Q000187:drug effects / Q000378:metabolism*
D000199:Actins; D047630:Depsipeptides; D010456:Peptides, Cyclic; C057531:jasplakinolide; D015638:Cytochalasin D